PHARMACY

Upsher-Smith wins HDA's DIANA award
Upsher-Smith was named Best Overall Branded Pharmaceutical Product Manufacturer with less than $300 million in sales.
Inmar Intelligence approved as Drug Take Back program operator by New York
Inmar’s all-inclusive, turnkey Drug Take-Back program includes a widespread network of accessible, user-friendly drop boxes that residents can use to safely dispose of unwanted prescription medications.

Senate HELP Committee passes food, drug legislative package, with provision lifting animal testing mandate

The FDA Modernization Act rider will spare animals, drive down drug prices and produce safer treatments and cures, said Animal Wellness Action.
Coram, CVS Specialty Infusion Services in Albany, N.Y., to close

Seventy Coram employees are affected by the upcoming closure on Sept. 18.
Reimagining the retail front end

In his latest column, DSN editor and chief Nigel Maynard highlights how some retail pharmacies are reexamining their SKUs as healthcare services expand and supply chain constraints cause a shortage of new products.
Pharmacy groups dismiss lawsuit after win on DIR

The new CMS rule on Part D makes litigation unnecessary, said NCPA and APhA, the lead plaintiffs.
Ascend Labs receives 2 DIANA awards

Ascend was recognized as a First Merit finalist in the Best Overall Generic Pharmaceutical Product Manufacturer with more than $100 million in sales category.
Amgen’s Rituxan biosimilar gets FDA OK for new indication

Amgen’s Riabni is now also approved for adults with moderate to severe rheumatoid arthritis.
Camber intros generic Trileptal

The medication is indicated as monotherapy or adjunctive therapy in the treatment of partial-onset seizures in adults.
GSK obtains FDA nod for Priorix

Priorix (measles, mumps and rubella vaccine, live) is indicated for active immunization for the prevention of measles, mumps and rubella in individuals aged 12 months old and older.